| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/25/2011 | CA2468180C Anti-proliferative composition |
| 01/25/2011 | CA2458690C Pharmaceutical compositions comprising an ascomycin derivative |
| 01/25/2011 | CA2457856C Sulphonated meso-tetraphenyl chlorins and their use as therapeutic agents |
| 01/25/2011 | CA2454532C Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities |
| 01/25/2011 | CA2447765C 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors |
| 01/25/2011 | CA2434299C Tricyclic androgen receptor modulator compounds and methods |
| 01/25/2011 | CA2410000C Compositions and methods comprising plasmid dna for wound healing and for repairing and regenerating tissue |
| 01/25/2011 | CA2388468C Mediators of hedgehog signalling pathways, compositions and uses related thereto |
| 01/25/2011 | CA2385322C A substantially cell membrane impermeable compound and use thereof |
| 01/25/2011 | CA2381882C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/25/2011 | CA2317455C Hydroxamic and carboxylic acid derivatives |
| 01/20/2011 | WO2011009075A2 Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses |
| 01/20/2011 | WO2011008086A1 Mixture of non-digestible oligosaccharides for stimulating the immune system |
| 01/20/2011 | WO2011007885A1 Proteoglycan-containing material |
| 01/20/2011 | WO2011007807A1 Method for manufacturing spilanthol and intermediate manufacturing product therefor |
| 01/20/2011 | WO2011007794A1 Zeolite and sericite-containing composition for medical or medical assisting uses |
| 01/20/2011 | WO2011007633A1 Crystals of pyrroloquinolinequinone sodium salts |
| 01/20/2011 | WO2011007337A2 Cosmetic use of lacritin-type polypeptides |
| 01/20/2011 | WO2010107287A3 Composition for trichogenousness using fetal mesenchymal stem cells from amniotic fluid |
| 01/20/2011 | WO2010090502A3 External use composition containing cholecalciferol or its derivative for treating skin disorders |
| 01/20/2011 | US20110015437 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 01/20/2011 | US20110015370 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 01/20/2011 | US20110015276 Therapeutical uses of inecalcitol |
| 01/20/2011 | US20110015240 Thiazole derivative and use thereof as vap-1 inhibitor |
| 01/20/2011 | US20110015230 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |
| 01/20/2011 | US20110015212 Pyrimidinones as pi3k inhibitors |
| 01/20/2011 | US20110015211 Fibrosis inhibitor |
| 01/20/2011 | US20110015195 Aryl ureas with angiogenisis inhibiting activity |
| 01/20/2011 | US20110015188 Treatment of Seasonal Conditions |
| 01/20/2011 | US20110015184 Vinyl-phenyl derivatives for inflammation and immune-related uses |
| 01/20/2011 | US20110015178 Amido-Thiophene Compounds and Their Use |
| 01/20/2011 | US20110015171 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 01/20/2011 | US20110015161 Pharmaceutical containing a horomone combination having a contraceptive effecr and an insulin sensitizer |
| 01/20/2011 | US20110015157 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 01/20/2011 | US20110015155 Deuterated 2, 4-Pyrimidinediamine Compounds and Prodrugs Thereof and Their Uses |
| 01/20/2011 | US20110015143 Use Of One Or More Of Glycyrrhizic Acid For Reducing The Irritating Action Of Surfactants In Cosmetic Compositions |
| 01/20/2011 | US20110015125 Adhesives and methods of applying the same |
| 01/20/2011 | US20110015120 Pharmaceutical and cosmetic compositions including lactoferrin, ciclopirox, etidronic acid |
| 01/20/2011 | US20110014308 Novel compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders. |
| 01/20/2011 | US20110014306 Formulations with sanguinarine, chelerythrine or chelidonine for the treatment of warts, verrucas and psoriatic plaques |
| 01/20/2011 | US20110014287 Silk Fibroin Hydrogels and Uses Thereof |
| 01/20/2011 | US20110014276 Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide |
| 01/20/2011 | US20110014251 Microvesicles |
| 01/20/2011 | US20110014250 Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation of the skin or skin appendages |
| 01/20/2011 | US20110014248 Cosmetic use of microorganism(s) for the treatment of scalp disorders |
| 01/20/2011 | US20110014189 Stable pharmaceutical composition comprising at least one monoclonal antibody and at least one amphiphilic polysaccharide comprising hydrophobic substituents |
| 01/20/2011 | US20110014180 Preparations for tissue restoration containing atrial diuretic hormone and family molecules as active ingredients; method of restoring tissue using the preparation; agents for growing, restoring, promoting growth of hair and agents for promoting restoration of skin tissue and cardiac muscle tissue containing atrial diuretic hormone family molecules as active ingredients; method of growing, restoring, promoting growth of hair by using the agents; and method of promoting restoration of skin tissue and cardiac muscle tissue |
| 01/20/2011 | US20110014175 Stimulation of the synthesis of the activity of an isoform of lysl oxidase-like loxl for stimulating the formation of elastic fibres |
| 01/20/2011 | US20110014164 Efficient induction of pluripotent stem cells using small molecule compounds |
| 01/20/2011 | US20110014153 Reinforced tissue graft |
| 01/20/2011 | US20110014149 Composition for skin external application containing complex of herbal extracts |
| 01/20/2011 | US20110014137 Methods for protecting the skin from radiation insults |
| 01/20/2011 | US20110014135 Vitamin formulation |
| 01/20/2011 | CA2768368A1 Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses |
| 01/20/2011 | CA2768015A1 Tazarotene derivatives |
| 01/19/2011 | EP2275557A1 Albumin fusion proteins |
| 01/19/2011 | EP2275548A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 01/19/2011 | EP2275437A1 Polypeptide and pharmaceutical composition containing the polypeptide |
| 01/19/2011 | EP2275416A1 Biologically active methylene blue derivatives |
| 01/19/2011 | EP2275411A2 Reformatsky Reagent in Stable Form and Process for Producing the Same |
| 01/19/2011 | EP2275140A2 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities |
| 01/19/2011 | EP2275104A2 Pharmaceutical and cosmetic composition including lactoferrin, ciclopirox and etidronic acid |
| 01/19/2011 | EP2275102A1 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 01/19/2011 | EP2275101A1 Polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes, and its uses |
| 01/19/2011 | EP2275083A1 Extract produced from orchid family plant, method for production thereof, and preparation for external application to skin comprising extract produced from orchid family plant |
| 01/19/2011 | EP2274419A1 Methods for producing hair microfollicles and de novo papillae and their use for in vitro tests and in vivo implantations |
| 01/19/2011 | EP2274302A2 Compounds and compositions as itpkb inhibitors |
| 01/19/2011 | EP2274015A2 Controlled release of active agents from oleosomes |
| 01/19/2011 | EP2274014A2 Stabilized oleosome preparations and methods of making them |
| 01/19/2011 | EP2274006A2 Angiostatic compositions comprising truncated tyrosyl-trna synthetase polypeptides and methods of using same |
| 01/19/2011 | EP2274004A2 In vivo temporal control of activ at able matrix- degrading enzymes |
| 01/19/2011 | EP2273974A2 Proguanil to treat skin/mucosal diseases |
| 01/19/2011 | EP2273969A1 Topical composition for external use and process for producing the same |
| 01/19/2011 | EP1481969B1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient |
| 01/19/2011 | EP1448995B1 Assay for screening candidate drugs for the treatment of inflammatory diseases |
| 01/19/2011 | EP1409008B1 Use of a nucleic acid molecule coding the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 01/19/2011 | EP1337234B1 Use of 2-oxothiazolidine 4-carboxylic acid derivatives as agents promoting skin peeling |
| 01/19/2011 | EP1185296B1 Prevention and treatment of amyloidogenic diseases |
| 01/19/2011 | CN201710546U Health-care ear cap adopting traditional Chinese medicines |
| 01/19/2011 | CN1935181B Animal medicament with the functioin of curing infectious bronchitis of chicken, and its preparing method |
| 01/19/2011 | CN1660081B Skin externally used paste |
| 01/19/2011 | CN101952320A Material with immunogenicity |
| 01/19/2011 | CN101952238A Hydrocortisone derivatives and use thereof for therapeutic or cosmetic indications |
| 01/19/2011 | CN101951944A Topical application and formulation of erythropoietin for skin wound healing |
| 01/19/2011 | CN101951941A Methods for inhibiting scarring |
| 01/19/2011 | CN101951929A External preparation for preventive or therapeutic use |
| 01/19/2011 | CN101951915A Oxsterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and WNT signaling |
| 01/19/2011 | CN101948539A IL-18 binding proteins |
| 01/19/2011 | CN101948464A 3,4,6-triaryl-(1,3)-oxazine-2-ketone compound as well as preparation method and application thereof |
| 01/19/2011 | CN101948439A Extraction method and application to medicine of active alkaloid compounds in cervus nippon temminck |
| 01/19/2011 | CN101948416A Compound used for treating metabolic disorder |
| 01/19/2011 | CN101947368A Flame-retardant body strengthening safety clothing of nano-element fiber fabric |
| 01/19/2011 | CN101947314A Novel aqua for treating beriberi and preparation process thereof |
| 01/19/2011 | CN101947313A Novel effervescent tablet for treating beriberi and preparation process thereof |
| 01/19/2011 | CN101947312A Modified polyethylene glycol superoxide dismutase (mPEG-SOD) nanoemulsion capable of being directly externally used for skin and preparation method thereof |
| 01/19/2011 | CN101947306A Treatment of T-cell mediated diseases |
| 01/19/2011 | CN101947294A Medicament for treating yellow fluid ulcers |
| 01/19/2011 | CN101947272A Chinese medicinal liniment for treating impetigo |
| 01/19/2011 | CN101947271A Prescription for treating tinea |
| 01/19/2011 | CN101947269A Medicine for treating viral herpes |